Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,6211,640 of 20,252 grants

Active NON-SBIR/STTR RPGS
National Succinate Dehydrogenase-deficient GIST Translational Research and Clinical Trial Consortium
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Gastrointestinal stromal tumor (GIST) is often effectively treated with FDA-approved first-line therapies such as imatinib and avapritinib. However, this s...

$5.5M
USD
Active NON-SBIR/STTR RPGS
MS4A7 in tumor resistance to immunotherapy
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

Project Summary/Abstract: Macrophages are one of the major cellular elements in the tumor microenvironment (TME). Tumor associated macrophages (TAMs) markedly outnumber dendritic c...

$6.51M
USD
Active NON-SBIR/STTR RPGS
Targeting ß-TrCP regulators to improve CRC response to chemotherapy
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2024 – 2029

PROJECT SUMMARY Improved treatment of colorectal cancer (CRC) requires better understanding of key regulators of survival and proliferation of intestinal epithelial cells and their...

$7.02M
USD
Completed NON-SBIR/STTR RPGS
The Role of Platelets in Cancer Cachexia
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2024 – 2026

SUMMARY Cancer cachexia is a complex metabolic syndrome characterized by muscle wasting, weight loss, and decreased quality of life. Patients with cancer cachexia experience impair...

$2.04M
USD
Completed NON-SBIR/STTR RPGS
Elucidating molecular mechanisms of cabozantinib resistance in liver cancer
NATIONAL CANCER INSTITUTE Loyola University Chicago United States 2024 – 2026

ABSTRACT Despite advancements in targeted molecular therapies, hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with an average 5-year survival r...

$770K
USD
Active NON-SBIR/STTR RPGS
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

Abstract: The rapid diffusion of genetic testing across adult cancer diagnoses is a unique opportunity to personalize cancer treatment and prevention at the population level. Germl...

$7.08M
USD
Active NON-SBIR/STTR RPGS
Molecular Markers for Tumors Associated with Extrachromosomal HPV
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2024 – 2029

3URMHFW 6XPPDU\ In the classical paradigm for cervical cancer, keratinocytes are infected with high-risk HPV (HR-HPV) genomes which become integrated (“iHPV”) into human chromosome...

$5.87M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of paclitaxel sensitivity and resistance
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

SUMMARY The microtubule poison paclitaxel (PTX) is standard-of-care for breast cancer treatment for all breast cancer subtypes in both early stage and metastatic disease. However,...

$5.29M
USD
Active NON-SBIR/STTR RPGS
The combined role of ARID1A loss and estrogen signaling in endometrial cancer
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2029

PROJECT SUMMARY Endometrial cancer is the most common gynecological cancer in the United States and causes more than 12,500 deaths per year with rising incidence and mortality as w...

$4.22M
USD
Completed SBIR-STTR RPGS
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer
NATIONAL CANCER INSTITUTE Duo Oncology Inc United States 2024 – 2024

EXECUTIVE SUMMARY Cancers rich in dense stromal tissue are more difficult to treat and carry a worse prognosis than cancers without the stroma-rich phenotype. The fibrous stroma su...

$550K
USD
Completed TRAINING, INDIVIDUAL
Clock Disruption Accelerates Colorectal Cancer and Promotes Immunosuppression
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2024

ABSTRACT Colorectal cancer (CRC) is the third most diagnosed cancer in the United States. With increasing public knowledge of cancer risk factors and screening, the incidence of CR...

$313.3K
USD
Active NON-SBIR/STTR RPGS
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth.
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2029

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, resulting in occupancy of most of the tumor mass by a dense stroma consisting of...

$7.25M
USD
Active NON-SBIR/STTR RPGS
Dissecting high-risk cell states in neuroblastoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Relapsed disease is a key challenge in cancer biology and medicine. Cancer cells are dynamic and exist in flexibly interconverting and epigenetically-spec...

$6.13M
USD
Completed NON-SBIR/STTR RPGS
Non-receptor protein tyrosine phosphatases in macrophage-mediated cancer cell phagocytosis.
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2026

Project Summary/Abstract Recent breakthroughs in tumor immunology led to the development of cancer immunotherapies which have been successfully applied to a range of human cancers....

$2.08M
USD
Completed NON-SBIR/STTR RPGS
Role of the tRNA methyltransferase AlkBH8 in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2026

Project Summary: Reactive Oxygen Species (ROS) are produced as byproducts of oxidative phosphorylation and are found to be elevated in most cancers. In order to prevent ROS mediate...

$2.11M
USD
Completed OTHER RESEARCH-RELATED
Deciphering the role of mitochondrial metabolism in liver cancer
NATIONAL CANCER INSTITUTE Rockefeller University United States 2024 – 2026

Project Summary: Liver cancer is the third leading cause of cancer-related death and is associated with diverse range of oncogenic alterations. These driver mutations impact clinic...

$1.42M
USD
Active TRAINING, INDIVIDUAL
Functionally dissecting MECOM gene regulation in high-risk leukemia
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a devastating disease that continues to have a poor prognosis with less than one-third of patients achieving a cure from th...

$432K
USD
Active TRAINING, INDIVIDUAL
Paracrine signaling from keratinocytes establishes a pro-melanoma environment
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2027

Project Summary Keratinocytes and melanocytes together form the epidermal melanin unit, which is essential for the protective tanning response after ultraviolet radiation (UV) expo...

$441.9K
USD
Active NON-SBIR/STTR RPGS
High-Precision Proton Therapy for Liver Cancer: Developing an End-to-end Strategy with Real-time Liver Tumor Localization and On-the-fly Plan Delivery Adaptation
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY The recent advancement of stereotactic body radiotherapy (SBRT) enables highly focused dose delivery to tumors while sparing surrounding normal tissues. Emerging cl...

$6.16M
USD
Active TRAINING, INDIVIDUAL
Directed Clonal Evolution of Drug Resistant BRAF Mutant Melanoma for Cross-Sensitization to MAPK Hyperactivation
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Targeted cancer therapeutics have traditionally focused on inhibiting activated oncogenic signaling pathways. While such pathway inhibitors have resulted i...

$742.8K
USD